跳至主要内容
临床试验/EUCTR2013-004028-12-IT
EUCTR2013-004028-12-IT进行中(未招募)不适用

Replacement therapy with modified-release hydrocortisone (Plenadren) in patients with central adrenal insufficiency - PLEN2013

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico0 个研究点开始时间: 2014年1月22日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age > 18 years
  • Diagnosis of central hypoadrenalism
  • Other pituitary deficiencies in adequate replacement therapy
  • Therapy with cortisone acetate from at least six months
  • Symptoms of over- and under-treatment
  • Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • Breast feeding
  • Estroprogestinic therapy
  • Steroids assumption

研究者

相似试验